British Columbia Investment Management Corp Neurocrine Biosciences Inc Transaction History

British Columbia Investment Management Corp

$16.2 Billion
Q2 2024

A detailed history of British Columbia Investment Management Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, British Columbia Investment Management Corp holds 19,056 shares of NBIX stock, worth $2.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

19,056

Previous 11,730 62.46%

Holding current value

$2.39 Million

Previous $1.62 Million 62.21%

% of portfolio

0.02%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $958,680 - $1.05 Million	7,326 Added 62.46%	19,056 $2.62 Million
Q1 2024 May 14, 2024	BUY	$130.4 - $143.74 $64,808 - $71,438	497 Added 4.42%	11,730 $1.62 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $259,235 - $324,465	2,444 Added 27.81%	11,233 $1.48 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $20,591 - $24,120	230 Added 2.69%	8,789 $828,000
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $13,551 - $17,714	144 Added 1.71%	8,559 $866,000
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $98,075 - $116,768	-919 Reduced 9.85%	8,415 $1.01 Million
Q3 2022 Nov 10, 2022	SELL	$92.03 - $107.81 $150,284 - $176,053	-1,633 Reduced 14.89%	9,334 $991,000
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $278,755 - $368,057	-3,678 Reduced 25.11%	10,967 $1.07 Million
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $141,639 - $185,353	-1,955 Reduced 11.78%	14,645 $1.37 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $70,649 - $94,217	-887 Reduced 5.07%	16,600 $1.41 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $11,720 - $13,468	136 Added 0.78%	17,487 $1.68 Million
Q2 2021 Aug 09, 2021	BUY	$89.43 - $102.27 $252,192 - $288,401	2,820 Added 19.41%	17,351 $1.69 Million
Q1 2021 Apr 30, 2021	SELL	$87.57 - $119.4 $38,092 - $51,939	-435 Reduced 2.91%	14,531 $1.41 Million
Q4 2020 Feb 02, 2021	SELL	$86.91 - $108.33 $29,114 - $36,290	-335 Reduced 2.19%	14,966 $1.43 Million
Q3 2020 Nov 10, 2020	BUY	$96.16 - $135.15 $120,296 - $169,072	1,251 Added 8.9%	15,301 $1.47 Million
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $381,118 - $583,882	4,479 Added 46.8%	14,050 $1.71 Million
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $820,952 - $1.24 Million	-10,930 Reduced 53.31%	9,571 $828,000
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $1.78 Million - $2.43 Million	20,501 New	20,501 $2.2 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Neurocrine Biosciences Inc Transaction History